1 results match your criteria: "USA. Electronic address: Amanda.Amin@UHhospitals.org.[Affiliation]"
Safety of de-escalation of surgical intervention for atypical ductal hyperplasia on percutaneous biopsy: One size does not fit all.
Am J Surg
January 2023
Department of Surgery, The University of Kansas Health System, Kansas City, KS, USA. Electronic address:
Background: Oncologic safety of active monitoring (AM) for atypical ductal hyperplasia (ADH) on core-needle biopsy (CNB) is not well defined. We sought to define oncologic outcomes for AM to manage ADH meeting institutional predefined low-risk criteria (LOW).
Methods: ADH was diagnosed on CNB from 10/2015-03/2020.